A 24-year-old woman presents with wheeze and shortness of breath occurring twice per month, usually with viral upper respiratory infections. Spirometry confirms reversible airflow obstruction consistent with asthma. She currently uses a short-acting beta2-agonist inhaler as needed. According to the 2021 Canadian Thoracic Society asthma guideline update, what is the most appropriate change to her therapy?